文献速递消化道肿瘤与早癌消化内镜

假幽门化生与胃癌发生无关

Pseudopyloric Metaplasia Is Not Associated With the Development of Gastric Cancer.
PubMed 文献 · Am J Gastroenterol · 2021-01-01

该纵向队列研究纳入292例连续性萎缩性胃炎患者,随访4.2(3-17)年,评估基线胃体假幽门化生(不伴肠化生)与胃癌发生的关系。结果显示随访中5例发生胃癌、4例发生异型增生,均伴有基线及随访时胃体肠化生;基线不伴肠化生的假幽门化生未见癌变,提示单纯假幽门化生似乎与胃癌无关。

要点

  • 基线不伴胃体肠化生的假幽门化生患者随访4.2年未见胃癌或异型增生。
  • 所有发生胃癌或异型增生的患者均伴有胃体肠化生。
  • 不伴肠化生的假幽门化生与年轻、无恶性贫血及无严重胃体萎缩相关。

核心结论

  • 在4.2年随访中,基线为胃体假幽门化生不伴胃体肠化生的萎缩性胃炎患者未观察到胃癌或异型增生,因为这些病变均与胃体肠化生相关。
  • 单纯胃体假幽门化生似乎不与胃癌相关,胃癌发生似乎需要胃体肠化生作为必要步骤。

研究设计与样本

  • 纵向队列研究,纳入292例接受内镜-组织学监测的连续性胃体萎缩性胃炎患者。
  • 根据基线胃体假幽门化生是否伴胃体肠化生进行分层,评估最长随访期间胃肿瘤性病变的发生。

主要发现

  • 随访4.2(3-17)年,292例中基线胃体假幽门化生不伴胃体肠化生者62例(21.2%)。
  • 随访期间检出胃癌5例(1.7%)、胃异型增生4例(1.4%)。
  • 9例胃癌/异型增生患者在基线及随访时均存在胃体肠化生。
  • 年龄<50岁(OR 2.5)、无恶性贫血(OR 4.3)、无严重胃体萎缩(OR 2.3)与胃体假幽门化生不伴胃体肠化生相关。

临床怎么用

  • 对于胃体萎缩性胃炎患者,评估胃体肠化生可能比单纯假幽门化生更有助于胃癌风险分层。
  • 不伴胃体肠化生的假幽门化生可能提示疾病进展阶段较低,但仍需按现行监测策略随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Corpus atrophic gastritis (CAG) is associated with intestinal metaplasia (IM) and pseudopyloric metaplasia (PPM). Prospective data on corpus mucosa PPM and its link to the development of gastric cancer (GC) are lacking. This study aimed to investigate the relationship between the presence of corpus mucosa PPM at baseline and the development of GC at follow-up in patients with CAG. METHODS: A longitudinal cohort study was conducted on patients with consecutive CAG adhering to endoscopic-histological surveillance. Patients were stratified for the presence/absence of corpus PPM without concomitant corpus IM at baseline, and the occurrence of gastric neoplastic lesions at the longest available follow-up was assessed. RESULTS: A total of 292 patients with CAG with a follow-up of 4.2 (3-17) years were included. At baseline, corpus PPM without corpus IM was diagnosed in 62 patients (21.2%). At the follow-up, GC was detected in 5 patients (1.7%) and gastric dysplasia (GD) in 4 patients (1.4%). In all these 9 patients with GC/GD at the follow-up, corpus IM was present at baseline and follow-up. Age <50 years (odds ratio [OR] 2.5), absence of pernicious anemia (OR 4.3), and absence of severe corpus atrophy (OR 2.3) were associated with corpus PPM without corpus IM. DISCUSSION: At the 4.2-year follow-up, in patients with CAG characterized at baseline with corpus PPM without corpus IM, GC or GD was not observed because these lesions were consistently associated with corpus IM. Corpus PPM without corpus IM was associated with younger age, absence of pernicious anemia, and severe corpus atrophy, suggesting a lower stage of disease progression. Corpus PPM alone seems not to be associated with GC, whose development seems to require the presence of corpus IM as a necessary step.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Dilaghi E, Baldaro F, Pilozzi E, et al. Pseudopyloric Metaplasia Is Not Associated With the Development of Gastric Cancer. Am J Gastroenterol. 2021. PMID: 34313623. doi:10.14309/ajg.0000000000001390

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。